Eli Lilly and Co (LLY)
733.54
+8.67
(+1.20%)
USD |
NYSE |
Apr 26, 15:34
Eli Lilly 1 Year Total Returns (Daily): 89.92% for April 25, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| April 25, 2024 | 89.92% |
| April 24, 2024 | 92.58% |
| April 23, 2024 | 95.17% |
| April 22, 2024 | 91.41% |
| April 19, 2024 | 97.68% |
| April 18, 2024 | 103.3% |
| April 17, 2024 | 103.3% |
| April 16, 2024 | 100.9% |
| April 15, 2024 | 102.0% |
| April 12, 2024 | 105.4% |
| April 11, 2024 | 110.4% |
| April 10, 2024 | 109.3% |
| April 09, 2024 | 107.3% |
| April 08, 2024 | 112.8% |
| April 05, 2024 | 118.3% |
| April 04, 2024 | 118.4% |
| April 03, 2024 | 123.1% |
| April 02, 2024 | 124.3% |
| April 01, 2024 | 123.3% |
| March 28, 2024 | 132.3% |
| March 27, 2024 | 134.5% |
| March 26, 2024 | 132.4% |
| March 25, 2024 | 131.9% |
| March 22, 2024 | 134.8% |
| March 21, 2024 | 134.6% |
| Date | Value |
|---|---|
| March 20, 2024 | 133.6% |
| March 19, 2024 | 136.7% |
| March 18, 2024 | 133.6% |
| March 15, 2024 | 130.8% |
| March 14, 2024 | 134.5% |
| March 13, 2024 | 135.5% |
| March 12, 2024 | 141.6% |
| March 11, 2024 | 135.1% |
| March 08, 2024 | 145.9% |
| March 07, 2024 | 153.2% |
| March 06, 2024 | 146.5% |
| March 05, 2024 | 146.2% |
| March 04, 2024 | 150.9% |
| March 01, 2024 | 151.0% |
| February 29, 2024 | 144.2% |
| February 28, 2024 | 145.5% |
| February 27, 2024 | 143.6% |
| February 26, 2024 | 142.0% |
| February 23, 2024 | 136.9% |
| February 22, 2024 | 135.8% |
| February 21, 2024 | 129.6% |
| February 20, 2024 | 132.0% |
| February 16, 2024 | 141.8% |
| February 15, 2024 | 128.1% |
| February 14, 2024 | 119.7% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-5.12%
Minimum
Oct 08 2019
153.2%
Maximum
Mar 07 2024
44.95%
Average
40.73%
Median
Aug 04 2020
1 Year Total Returns (Daily) Benchmarks
| Amgen Inc | 13.71% |
| Biogen Inc | -28.31% |
| Madrigal Pharmaceuticals Inc | -34.28% |
| Vertex Pharmaceuticals Inc | 19.81% |
| Viking Therapeutics Inc | 246.4% |